Trial intelligence / Profile preview

TWICE: Ezetimibe Add-on to Statin in Hypercholesterolemia

NCT00328523Phase 3Completed

Sponsor
Organon & Co.
Start
Jun 2004
Primary completion
Jan 2006
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Jun 2004; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00328523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00328523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call